CompletedN/Aketamine

Lidocaine and Ketamine Levels in Plasma After Simultaneous Lidocaine/Ketamine Infusions

Sponsored by University Hospital, Basel, Switzerland

NCT ID
NCT05906121
Target Enrollment
15 participants
Start Date
2023-05-16
Est. Completion
2024-08-31

About This Study

The aim of this monocentric observational pilot study is to measure the lidocaine plasma level in a limited number of patients to generate explorative data on inter- and intrapersonal stability and safety of drug plasma levels and to investigate whether higher plasma levels of ketamine can be correlated with a better analgesic effect.

Conditions Studied

Chronic Pain

Interventions

  • lidocaine-ketamine infusions

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Patient is a new recipient of lidocaine-ketamine infusions
* Patient is able to provide Informed Consent

Exclusion Criteria:

* Contraindication to blood sampling (on arm not used for infusion)
* Insufficient knowledge of German language
* Inability to give consent
* Patient is under 18 years of age
* Contraindication to treatment with lidocaine and/or ketamine

Study Locations (1)

Department of Anaesthesiology, University Hospital of Basel (USB)
Basel, Switzerland

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source